Yongping Zhu

872 citations
36 papers · 594 indexed · h-index 13
Topics
Natural Compounds in Disease Treatment (6 papers)Malaria Research and Control (4 papers)Synthesis and Catalytic Reactions (3 papers)

In The Last Decade

Yongping Zhu

34 papers receiving 588 citations

Peers

Yongping Zhu
Comparison fields: 5 of 95
  • Molecular Biology 247
  • Organic Chemistry 96
  • Complementary and alternative medicine 71
  • Oncology 66
  • Immunology 66
Replace Lisa Gruber with:
Lisa Gruber Germany
Babajan Banaganapalli Saudi Arabia
Sook‐Kyoung Heo South Korea
Silvia Gervasoni Italy
Vineet Pande Belgium
Yixuan Wu China
Feng Feng China
Mi Jin Yoon South Korea
Stephan Miller United States
Yongping Zhu relative to Lisa Gruber Germany Lisa Gruber's profile →
Citations per field
00.5×5.2×
Lisa Gruber · 1×
Citations per year

Countries citing papers authored by Yongping Zhu

Since Specialization
Citations

This map shows the geographic impact of Yongping Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Zhu more than expected).

Fields of papers citing papers by Yongping Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Zhu. The network helps show where Yongping Zhu may publish in the future.

Co-authorship network of co-authors of Yongping Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Zhu. A scholar is included among the top collaborators of Yongping Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Zhu. Yongping Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 8
6 1
7 6
8 5
9 19
10 72
11 13
12 12
13 62
14 21
15 24
16 5
17 6
18 9
19 7
20 10

About Yongping Zhu

Yongping Zhu is a scholar working on Complementary and alternative medicine, Otorhinolaryngology and Cancer Research, having authored 36 papers that have together received 594 indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (6 papers), Malaria Research and Control (4 papers) and Synthesis and Catalytic Reactions (3 papers). The work is most often cited by research in Complementary and alternative medicine (71 citations), Cancer Research (59 citations) and Molecular Biology (247 citations). Yongping Zhu has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Jigang Wang, Yuqing Meng, Liwei Gu, Junzhe Zhang, Piao Luo, Yongfang Zhao, Peng Gao, Huifang Zhou, Xuejun C. Zhang and Nan Ma. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026